Piramal Healthcare is a part of the Piramal Enterprises Ltd. Led by Ajay G. Piramal, the Piramal Group is one of India's foremost business conglomerates. Emerging from a rich textile industry lineage, the Piramal Group has exemplified diversification by foraying into a myriad of industries that encompass healthcare, drug discovery and research, glass, real estate and financial services.
Piramal Pharma business is the contract development and manufacturing arm of Piramal | Healthcare. Our capability as an integrated solutions provider enables us to serve Innovator and Generic companies worldwide. Our customers can avail a comprehensive range of services across all phases of the drug lifecycle which includes drug discovery and development, manufacturing and packaging of clinical trial supplies, delivering commercial volumes of APIs as well as finished dosage products. To provide flexibility and scalability of operations, we have invested in a network of contract development and manufacturing facilities located in North America, Europe and Asia.
One of the top 10 custom manufacturing pharma companies in India, Europe and North America.
Our customers enjoy the benefits of our global network of assets spread across Europe, North America and Asia. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements.
With capabilities across drug discovery, development, scale-up and manufacturing of APIs as well as Formulations, we are well positioned to address customers' needs across the entire drug lifecycle. Our specialization in Antibody Drug Conjugation, Clinical Trial Supplies, Packaging and Biocatalysis enables us to provide differentiated services to our customers.
Piramal Enterprises Ltd., currently valued at more than 1 billion USD, is amongst the largest business conglomerates in India. We embrace a rich legacy of over20 years in the business of healthcare.
Consistent track record
We are a pioneer in the Contract Development and Manufacturing Services market and have an experience of over two decades. We have advanced manufacturing facilities approved by leading regulatory agencies including the US-FDA and MHRA. We are a trusted supplier to more than 100 pharma companies across the US, Europe and Japan including all major big pharma and large generic companies.
People and science
Our R&D team is led by scientists with experience of working with pharma companies across the globe and hold expertise across various chemistries and range of formulation types.
Hallmark of Quality & Safety
We believe that the best can be delivered if only there is an internal focus on quality. Stringent quality and safety norms are followed across our facilities worldwide.
Products and services
Piramal Pharma Solutions has globally integrated model of operations with a network of assets across North America, Europe and Asia for meeting the needs of the entire Pharmaceutical Industry - starting from small biotech companies to Big Pharma.
We offer services across the drug lifecycle.
Drug discovery solutions
We, are an integral part of Piramal Pharma Solutions and deliver early stage drug discovery services to pharma companies, biotech companies and academic institutions. Our 10,000 m2; (100,000+ ft2;) greenfield campus is located in a Special Economic Zone (SEZ), which is a government sponsored industrial park with specialized infrastructure to encourage export and industrialization. Our campus benefits from on-site customs clearance, central waste and power management and secure buildings with access control points.
Our modern and advanced facility hosts 28 lab units (12 fume-hood reconfigurable modules), a write-up area and research campus that accommodates over 300 scientists.
We offer services for all API needs from discovery services to development of a process, supplies for clinical trials to commercial manufacturing and supply. We are an integrated global solutions provider and have the flexibility of simultaneously engaging our facilities to ensure a speedy delivery through parallel development, proximity to market and a saving in development costs through our facilities in Canada, Europe and India.
We also offer specialized services in the form of biocatalysis. Biocatalysis enables harnessing of the superior stereoselectivity, chemoselectivity and regioselectivity of nature's catalysts for the synthesis of complex molecules.
Formulation development and manufacturing services
We are uniquely positioned to offer services to fulfill your formulation requirements from pre-formulation studies, formulation development to commercial manufacturing and developing alternate formulations for late lifecycle challenges.
Our extensive range of capabilities cover all categories of dosage forms including special technology platforms namely Surge Dose, press coated tablets and taste masking technology to support line extensions and lifecycle management of products.
Antibody drug conjugation
We are the pioneers in the field of GMP manufacturing of antibody drug conjugate products with a wealth of experience in proof of concept studies to scale up and commercial supplies. Our facility in Scotland is dedicated to process development, scale up and manufacturing of Bioconjugates with primary focus on ADCs. For over a decade, we have partnered with leading ADC technology companies and their licensees to develop robust processes used in pre-clinical, clinical and commercial supplies. We have made over 460 batches (>240 GMP batches) of ADCs spanning more than 60 distinct ADC candidates.
Pharma Solutions has developed a range of off-patent APIs for global markets. We have a presence in over 63 countries with an established network of distributors in several Asian, Latin American and EU countries. We supply leading Generic and big pharma companies from our network of internationally compliant manufacturing sites across North America, the UK and India.
We develop and commercialize off-patent APIs and supply to our Global customers. We have a product basket of 18 APIs with DMFs and other regulatory filings and a pipeline of about 20 APIs at various stages of development.
Clinical research organization
Piramal Clinical Research is a contract research organization specialized in bioequivalence and analytical studies. With state-of-the-art facility spread over 30,000ft2 at Hyderabad, India, Piramal Clinical Research has capabilities for conducting bioavailability and bioequivalence studies, bioanalytical method development and validation, sample processing and analysis, statistical analysis and reporting.
It is managed by a group of dedicated professionals with vast experience in clinical research. At Piramal Clinical Research, all operations are driven by GCP and GLP systems as well as applicable national and international regulations. Piramal Clinical Research has more than 150 SOPs for clinical, bioanalytical and QA operations and more than 125 validated methods.
We have been involved in more than 100 pivotal bioequivalence and pharmacokinetic studies with expertise in analytical work for new chemical entities (Phase I-III studies). Most of these studies have been carried out for international regulatory submissions - these include US FDA, UK MHRA, European Union, MCC-South Africa, and Thailand FDA. Piramal Clinical Research is authorized by the Drugs Controller General (India) and has been inspected by the US FDA and Department of Medical Sciences, Ministry of Public Health (Thailand). Our clients have received product approval for generics in US and EU for which the biostudies were done at Piramal Clinical Research.